## Diagnosis: Stage 1 Hypertension Without End-Organ Damage This patient has **newly diagnosed hypertension** (BP consistently ≥140/90 mmHg) with **no evidence of end-organ damage** and **no secondary causes**. ### Blood Pressure Classification (ACC/AHA 2017) | Category | Systolic (mmHg) | Diastolic (mmHg) | Action | |---|---|---|---| | **Normal** | <120 | <80 | Lifestyle | | **Elevated** | 120–129 | <80 | Lifestyle | | **Stage 1 HTN** | 130–139 | 80–89 | Lifestyle ± drugs (individualized) | | **Stage 2 HTN** | ≥140 | ≥90 | Lifestyle + drugs | | **HTN Emergency** | >180 | >120 | + end-organ damage | IV agents, ICU | **Key Point:** In the **absence of end-organ damage, diabetes, or CVD**, Stage 1 hypertension is managed with **lifestyle modification first** for 3–6 months before initiating pharmacotherapy. This approach is supported by major guidelines (ACC/AHA, ESC, Indian guidelines). ### Lifestyle Modifications (DASH Approach) ```mermaid flowchart TD A["Newly diagnosed HTN, no end-organ damage"]:::outcome --> B["Initiate Lifestyle Modifications"]:::action B --> C["DASH diet: fruits, vegetables, whole grains"]:::action B --> D["Sodium restriction: <2.3 g/day"]:::action B --> E["Weight loss: 5-10% if overweight"]:::action B --> F["Regular aerobic exercise: 150 min/week"]:::action B --> G["Limit alcohol, stress management"]:::action H["Repeat BP monitoring at 3 months"]:::decision C --> H D --> H E --> H F --> H G --> H H -->|"BP controlled <140/90"| I["Continue lifestyle, follow-up annually"]:::outcome H -->|"BP still ≥140/90"| J["Initiate antihypertensive drug therapy"]:::action ``` **High-Yield:** The **DASH diet** (Dietary Approaches to Stop Hypertension) can reduce BP by 8–14 mmHg — equivalent to a single antihypertensive drug. Combined lifestyle modifications can reduce BP by 20–30 mmHg. **Clinical Pearl:** Lifestyle modification is **first-line** in newly diagnosed hypertension without end-organ damage. It reduces cardiovascular risk, improves overall health, and may prevent or delay need for medications. Rushing to pharmacotherapy in a low-risk patient increases polypharmacy and cost without proven benefit. **Mnemonic: DASH** — **D**airy (low-fat), **A**lkaline foods (fruits/vegetables), **S**odium restriction, **H**ealthy fats (unsaturated). **Warning:** Do NOT confuse this with hypertensive urgency or emergency — those require immediate drug therapy. This patient has stable, asymptomatic Stage 1 HTN and is an ideal candidate for lifestyle-first approach. [cite:Harrison 21e Ch 298; Park 26e Ch 8]
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.